GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2386.1 and 2423.1
| Intraday Target 1 | 2356.07 |
| Intraday Target 2 | 2379.13 |
| Intraday Target 3 | 2393.0666666667 |
| Intraday Target 4 | 2416.13 |
| Intraday Target 5 | 2430.07 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 06 July 2026 | 2402.20 (0.28%) | 2390.20 | 2370.00 - 2407.00 | 0.4475 times | Fri 03 July 2026 | 2395.50 (-0.84%) | 2415.80 | 2380.00 - 2426.70 | 0.4948 times | Thu 02 July 2026 | 2415.80 (-1.98%) | 2467.00 | 2405.00 - 2467.00 | 0.5463 times | Wed 01 July 2026 | 2464.70 (0.59%) | 2476.80 | 2426.80 - 2504.70 | 1.1603 times | Tue 30 June 2026 | 2450.30 (4.07%) | 2365.60 | 2335.40 - 2460.90 | 1.889 times | Mon 29 June 2026 | 2354.40 (-0.02%) | 2347.80 | 2343.20 - 2408.90 | 1.4003 times | Thu 25 June 2026 | 2354.80 (-0.5%) | 2360.00 | 2333.10 - 2386.60 | 1.0311 times | Wed 24 June 2026 | 2366.60 (-1.26%) | 2396.90 | 2360.10 - 2398.90 | 0.8695 times | Tue 23 June 2026 | 2396.70 (1.42%) | 2369.90 | 2355.10 - 2404.80 | 1.0006 times | Mon 22 June 2026 | 2363.10 (1.33%) | 2358.10 | 2322.30 - 2375.90 | 1.1606 times | Fri 19 June 2026 | 2332.00 (2.9%) | 2260.00 | 2237.60 - 2350.00 | 2.1821 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2386.1 and 2423.1
| Weekly Target 1 | 2356.07 |
| Weekly Target 2 | 2379.13 |
| Weekly Target 3 | 2393.0666666667 |
| Weekly Target 4 | 2416.13 |
| Weekly Target 5 | 2430.07 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 06 July 2026 | 2402.20 (0.28%) | 2390.20 | 2370.00 - 2407.00 | 0.0946 times | Fri 03 July 2026 | 2395.50 (1.73%) | 2347.80 | 2335.40 - 2504.70 | 1.1602 times | Thu 25 June 2026 | 2354.80 (0.98%) | 2358.10 | 2322.30 - 2404.80 | 0.8583 times | Fri 19 June 2026 | 2332.00 (9.92%) | 2135.10 | 2111.00 - 2350.00 | 1.9576 times | Fri 12 June 2026 | 2121.50 (-1.97%) | 2154.70 | 2088.10 - 2216.00 | 1.5261 times | Fri 05 June 2026 | 2164.10 (-2.09%) | 2200.00 | 2154.00 - 2219.90 | 0.5395 times | Fri 29 May 2026 | 2210.20 (-4.19%) | 2329.00 | 2194.40 - 2341.00 | 1.3742 times | Fri 22 May 2026 | 2306.90 (-5.41%) | 2438.80 | 2297.00 - 2440.00 | 0.9494 times | Fri 15 May 2026 | 2438.80 (-1.54%) | 2476.90 | 2400.00 - 2520.00 | 0.6516 times | Fri 08 May 2026 | 2476.90 (6.01%) | 2342.00 | 2322.50 - 2504.90 | 0.8886 times | Thu 30 April 2026 | 2336.40 (-5.49%) | 2472.00 | 2319.40 - 2495.00 | 0.8233 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2318.75 and 2453.45
| Monthly Target 1 | 2290.93 |
| Monthly Target 2 | 2346.57 |
| Monthly Target 3 | 2425.6333333333 |
| Monthly Target 4 | 2481.27 |
| Monthly Target 5 | 2560.33 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 06 July 2026 | 2402.20 (-1.96%) | 2476.80 | 2370.00 - 2504.70 | 0.191 times | Tue 30 June 2026 | 2450.30 (10.86%) | 2200.00 | 2088.10 - 2460.90 | 1.9033 times | Fri 29 May 2026 | 2210.20 (-5.4%) | 2342.00 | 2194.40 - 2520.00 | 1.3187 times | Thu 30 April 2026 | 2336.40 (2.34%) | 2305.00 | 2261.90 - 2529.90 | 0.8122 times | Mon 30 March 2026 | 2283.00 (-11.22%) | 2520.00 | 2217.60 - 2581.60 | 0.6545 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.955 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.8531 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.3942 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.1629 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.7551 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 1.2029 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 1929.3 and 2561
| Yearly Target 1 | 1771.67 |
| Yearly Target 2 | 2086.93 |
| Yearly Target 3 | 2403.3666666667 |
| Yearly Target 4 | 2718.63 |
| Yearly Target 5 | 3035.07 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 06 July 2026 | 2402.20 (-2.89%) | 2476.00 | 2088.10 - 2719.80 | 0.5798 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.556 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.1731 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.208 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7016 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9359 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0445 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4468 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2272 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1271 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1273 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in uptrend. And this trend seems to be continuing further.
Price is above an important level of 2368.67 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO made a big move recently. This generally happens when there is a positive sentiment change, or a block deal went through. There is a good chance that this trend might continue in coming days.
Munafa value: 75 as on Mon 06 July 2026
This Munafa value indicates that the stock is moving upwards and might continue to move up.
SMA20 is at 2294 and price is deviating by 117 points
Upper Bollinger band is at 2526 and lower is at 2062, while middle bands are at 2178 and 2410
Price is rising
Price is above 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for GlaxosmithklinePharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
GlaxosmithklinePharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2399.18 and GlaxosmithklinePharmaceuticals GLAXO stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2425.7 |
| 12 day DMA | 2380.19 |
| 20 day DMA | 2293.28 |
| 35 day DMA | 2287.19 |
| 50 day DMA | 2327.58 |
| 100 day DMA | 2398.4 |
| 150 day DMA | 2419.64 |
| 200 day DMA | 2482.38 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2404.78 | 2406.07 | 2411.35 |
| 12 day EMA | 2368.69 | 2362.6 | 2356.62 |
| 20 day EMA | 2339.33 | 2332.71 | 2326.1 |
| 35 day EMA | 2338.04 | 2334.26 | 2330.65 |
| 50 day EMA | 2346.24 | 2343.96 | 2341.86 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2425.7 | 2416.14 | 2408 |
| 12 day SMA | 2380.19 | 2363.33 | 2347.27 |
| 20 day SMA | 2293.28 | 2281.37 | 2269.93 |
| 35 day SMA | 2287.19 | 2287.61 | 2288.07 |
| 50 day SMA | 2327.58 | 2328.85 | 2329.49 |
| 100 day SMA | 2398.4 | 2398.45 | 2398.85 |
| 150 day SMA | 2419.64 | 2420.14 | 2420.82 |
| 200 day SMA | 2482.38 | 2484.56 | 2486.68 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 61.15 and PE is: 39.28
Last quarter profit: (March 2026 quarter) 277.86 crores (5.70%)
Debt: 33.27 in crores
Market capitalization: 39891.73
EPS is 60.27 and PE is: 39.86
Last quarter profit: (December 2025 quarter) 295.62 crores (22.82%)
Debt: 35.71 in crores
Market capitalization: 38277.29
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance


